NANOVEX BIOTECHNOLOGIES SL

Their core work

Nanovex Biotechnologies is a Spanish SME specializing in nanovesicle and nanoparticle manufacturing technology, with roots in magnetic nanostructure research for biomedical use. Their core commercial product appears to be equipment for producing nanovesicles — lipid-based nanocarriers used in drug delivery and diagnostics. They bridge fundamental nanotechnology research (magnetic nanostructures, protocells) with practical manufacturing solutions, positioning themselves as a supplier of nanoscale production tools rather than a pure research lab.

What they specialise in

How they've shifted over time

Nanovex began with a clear focus on magnetic nanoparticles for medical diagnostics (MAGNAMED, 2017), working on cancer-relevant nanostructures. By 2018, they diversified into fundamental science — contributing to origin-of-life research through protocell and metallopeptide work (ProtoMet). Their 2019 NANOGO project signals a commercial pivot toward manufacturing equipment for nanovesicles, moving from research participation toward product development and market entry.

Nanovex is moving from research contributor toward commercial nanoparticle/nanovesicle equipment manufacturer — future partners should expect a company increasingly focused on scalable production technology rather than basic science.

How they like to work

Nanovex operates across all roles — coordinator, participant, and third party — showing flexibility in how they engage with consortia. With 26 unique partners across 13 countries from just 3 projects, they plug into large international networks (MSCA-RISE and MSCA-ITN projects are typically 10+ partner consortia). Their willingness to join as a third party (ProtoMet) suggests they offer specialized nanotech capabilities that larger teams seek out on demand.

Despite only 3 projects, Nanovex has built a remarkably broad network of 26 partners across 13 countries, largely through participation in large MSCA mobility and training networks. Their reach spans well beyond Spain into a diverse European and potentially global set of collaborators.

What sets them apart

Nanovex occupies an unusual niche: a biotech SME that combines hands-on nanoparticle fabrication know-how with ambitions to commercialize the manufacturing equipment itself. Most nanotechnology SMEs either sell nanoparticles or conduct contract research — Nanovex targets the tooling layer, aiming to supply the machines that produce nanovesicles at scale. Their cross-disciplinary range (from cancer diagnostics to origin-of-life chemistry) demonstrates versatile nanoparticle expertise that adapts to diverse scientific contexts.

Highlights from their portfolio

• NANOGO
  Their only coordinated project and an SME Instrument Phase 1 grant — signals serious commercialization intent for their nanovesicle manufacturing equipment.
• MAGNAMED
  Large MSCA-RISE network on magnetic nanostructures for medicine, connecting Nanovex to an extensive international research community in biomedical nanotechnology.